84 related articles for article (PubMed ID: 10447448)
1. The Postal Service and cancer screening.
Catalona WJ
N Engl J Med; 1999 Aug; 341(7):542; author reply 543. PubMed ID: 10447448
[No Abstract] [Full Text] [Related]
2. The U.S. Postal Service and cancer screening--stamps of approval?
Woloshin S; Schwartz LM
N Engl J Med; 1999 Mar; 340(11):884-7. PubMed ID: 10080855
[No Abstract] [Full Text] [Related]
3. The Postal Service and cancer screening.
Bodai BI; Hunter DC
N Engl J Med; 1999 Aug; 341(7):543. PubMed ID: 10447451
[No Abstract] [Full Text] [Related]
4. In their own words. One man's mission against cancer.
Bodai E
Bull Am Coll Surg; 2001 Feb; 86(2):28-30. PubMed ID: 11351840
[No Abstract] [Full Text] [Related]
5. The Postal Service and cancer screening.
Silverstein SC
N Engl J Med; 1999 Aug; 341(7):542; author reply 543. PubMed ID: 10447450
[No Abstract] [Full Text] [Related]
6. The Postal Service and cancer screening.
Resnick MI
N Engl J Med; 1999 Aug; 341(7):542; author reply 543. PubMed ID: 10447449
[No Abstract] [Full Text] [Related]
7. Is prostate cancer screening bad or good? Summary of a debate at the innovation in urology meeting, September 17-19, 2010, Milan, Italy.
Roobol MJ
Eur Urol; 2011 Mar; 59(3):359-62. PubMed ID: 21035943
[No Abstract] [Full Text] [Related]
8. Prostate cancer screening: more harm than good?
Lefevre ML
Am Fam Physician; 1998 Aug; 58(2):432-8. PubMed ID: 9713397
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer options expand beyond the PSA.
Clin Resour Manag; 2002 May; 3(5):65-8. PubMed ID: 12048767
[No Abstract] [Full Text] [Related]
10. Prostate-cancer screening.
Catalona WJ
N Engl J Med; 2009 Jul; 361(2):202; author reply 204-5. PubMed ID: 19587348
[No Abstract] [Full Text] [Related]
11. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
12. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
Colli JL; Amling CL
Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
[TBL] [Abstract][Full Text] [Related]
13. Why the evidence for skin cancer screening is insufficient: lessons from prostate cancer screening.
Bigby M
Arch Dermatol; 2010 Mar; 146(3):322-4. PubMed ID: 20231506
[No Abstract] [Full Text] [Related]
14. Prostate cancer screening; is this a teachable moment?
Brawley OW
J Natl Cancer Inst; 2009 Oct; 101(19):1295-7. PubMed ID: 19720970
[No Abstract] [Full Text] [Related]
15. What is the value of screening for prostate cancer in the US?
Albertsen PC
Nat Clin Pract Oncol; 2005 Nov; 2(11):536-7. PubMed ID: 16270077
[No Abstract] [Full Text] [Related]
16. How can rates of prostate-specific antigen screening be reduced in men aged 80 and older?
Whittle J; Zablocki CJ
J Am Geriatr Soc; 2010 Apr; 58(4):757-9. PubMed ID: 20398158
[No Abstract] [Full Text] [Related]
17. Screening for prostate cancer: recommendations and rationale.
Berg AO;
Am J Nurs; 2003 Mar; 103(3):107-10; discussion 111. PubMed ID: 12626949
[No Abstract] [Full Text] [Related]
18. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
19. Update: prostate cancer screening.
Fulton JP; Lindenmayer JM
R I Med; 1995 Nov; 78(11):330-1. PubMed ID: 8547727
[No Abstract] [Full Text] [Related]
20. Cancer stamp raises awareness. Multicolored stamp depicts a female figure as a salute to survivors.
Herreria J
Profiles Healthc Mark; 1998; 14(6):47-8. PubMed ID: 10387291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
